Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a403827fb83690c0

Jump to content

Talk:GenScript Biotech

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 2 days ago by Athanelar in topic History Section

COI tag (May 2022)

[edit]

Undisclosed PAID; possible sock of Wikipedia:Sockpuppet_investigations/123Aristotle 虹易 (talk) 03:56, 26 May 2022 (UTC)Reply

13 May 2026 edit request

[edit]

Hello Wikipedia, my name is Melis and I would like to present a suggestion for this article. Currently, it only has a History section in addition to the normal lead and infobox. The sources used need to be updated generally to remove the old archive links and there are several instances of poor sourcing, including MarketScreener, a Forbes contributor piece, several press releases.

I would like to present editors with an updated version of this article in my User space. For easy review, here is a diff between my proposal and the current article.

My proposal updates the sources when possible and adds news sections including Operations, Production, and Research. Some of the information in the History section was moved to the more appropriate section.

I would love to hear any feedback editors may have. Thank you! Melis for GenScript (talk) 22:18, 13 May 2026 (UTC)Reply

Hi Melis for GenScript, thank you for proposed changes to the article. It helped me identify vandalism that had been unfixed in the article for months. However, it is quite difficult to assess wholesale article changes in a userspace article draft, and even though there is a diff included, it makes it hard to see specific section-by-section changes. For example, your draft of the article removes information currently in the article such as "In 2004, it set up a research and production base in Nanjing, China." and "In 2015, GenScript went public on the SEHK." without offering rationale for why this information should be removed. If you had something section-by-section (e.g. lead, infobox, history, etc.) highlighting removals, changes, and additions with rationale, it would make it much easier for impartial editors to review this request rather than having to closely scrutinize which information may have been removed without clear explanation. Best, SpencerT•C 22:27, 24 May 2026 (UTC)Reply
I understand! Let someone close out the request and I will post a smaller request in a new section below. Thanks! Melis for GenScript (talk) 05:50, 28 May 2026 (UTC)Reply

Operations section

[edit]

Per User:Spencer's request, I have taken the diff above and broken out a smaller request from it. I would like to focus on the proposed Operations section first, since it is all additions.

Draft:

GenScript is headquartered in Piscataway, New Jersey.[1] It established presences in the United States, China, Singapore, Japan, the United Kingdom, and the Netherlands, among others.[2]

GenScript's operations are divided into life-science services and products, biologics CDMO, and industrial enzymes.[3]

The company was founded by Frank Zhang,[4] Sally Wang,[5] and Larry Wang.[6] As of 2026, leadership included Robin Meng, chairman;[7] Sherry Shao, rotating CEO;[8] and Ray Chen, Life Science Group president.[1] Its scientific advisory board includes George Church, Carl June, and David R. Liu, as of 2026.[9]

GenScript has operations in over 100 countries and over 250,000 customers, as of 2025. That year, its revenue was $959.5 million and it had over 6,165 employees.[10]

References

  1. 1 2 Keenan, Joseph (2 November 2021). "GenScript embraces automation at its first cell, gene therapy manufacturing US site". Fierce Pharma. Retrieved 8 January 2026.
  2. "GenScript Launches A Protein Manufacturing Facility In Singapore". Lianhe Zaobao. Economic Development Board. January 10, 2023.
  3. Dutton, Gail (6 March 2019). "A Genetic Gold Rush Requires Biomolecular Tools". GEN - Genetic Engineering and Biotechnology News. Retrieved 11 February 2026.
  4. Feng, Venus; Lee, Yoojung (31 May 2018). "Road to China Drug Riches Runs Through the Bronx, New Jersey". Bloomberg. Retrieved 8 January 2026.
  5. Chen, I-Chun (9 November 2020). "Legend Biotech names Huang permanent CEO, Wang chairwoman". New York Business Journal. Retrieved 8 January 2026.
  6. "RESIGNATION OF ROTATING CHIEF EXECUTIVE OFFICER" (PDF). hkexnews.hk. GenScript. Retrieved 8 January 2026.
  7. "Meng Jiange "Robin" Bloomberg". Bloomberg. Bloomberg. Retrieved 9 April 2026.
  8. Dunleavy, Kevin (11 November 2024). "GenScript sets up operations and logistics center in Australia". Fierce Pharma. Retrieved 8 January 2026.
  9. "Advisory Board". www.genscript.com. GenScript. Retrieved 11 February 2026.
  10. "Annual Results Announcement For The Year Ended December 31, 2025" (PDF). hkexnews.hk. GenScript. Retrieved 9 April 2026.


I will propose subsections for this in the future if it is accepted, but those borrow from current content so I wanted to present something entirely new for editors to consider. Thanks! Melis for GenScript (talk) 05:50, 28 May 2026 (UTC)Reply

The U.S. subsidiary is based in New Jersey, not the parent company. This article is about the parent company. - Amigao (talk) 20:25, 28 May 2026 (UTC)Reply
@Amigao: I see what you mean. What about phrasing such as, "GenScript has principal offices in Nanjing, China and Piscataway, New Jersey"?
Let me know what you think! Melis for GenScript (talk) 21:07, 10 June 2026 (UTC)Reply
That is not very clear. The parent company is headquartered in China, which is the topic of this article. The New Jersey operations are run by the U.S. subsidiary. - Amigao (talk) 21:12, 10 June 2026 (UTC)Reply
@Amigao: I understand. Do you have any thoughts about the rest of the proposal? Perhaps for now it is best to omit this sentence entirely and focus on just the Operations section addition and the rest of the content. Melis for GenScript (talk) 21:58, 15 June 2026 (UTC)Reply
Omitting that fact would then paint a less complete and clear picture. Why would we want to remove where the parent company is based? - Amigao (talk) 02:01, 16 June 2026 (UTC)Reply

@Amigao: I understand. Would you be willing to consider the draft below, which revises the first sentence of my proposal?

Draft:

GenScript Biotech Corporation is headquartered in Nanjing, China.[1] It established presences in the United States, China, Singapore, Japan, the United Kingdom, and the Netherlands, among others.[2]

GenScript's operations are divided into life-science services and products, biologics CDMO, and industrial enzymes.[3]

The company was founded by Frank Zhang,[4] Sally Wang,[5] and Larry Wang.[6] As of 2026, leadership included Robin Meng, chairman;[7] Sherry Shao, rotating CEO;[8] and Ray Chen, Life Science Group president.[1] Its scientific advisory board includes George Church, Carl June, and David R. Liu, as of 2026.[9]

GenScript has operations in over 100 countries and over 250,000 customers, as of 2025. That year, its revenue was $959.5 million and it had over 6,165 employees.[10]

References

  1. 1 2 Keenan, Joseph (2 November 2021). "GenScript embraces automation at its first cell, gene therapy manufacturing US site". Fierce Pharma. Retrieved 8 January 2026.
  2. "GenScript Launches A Protein Manufacturing Facility In Singapore". Lianhe Zaobao. Economic Development Board. January 10, 2023.
  3. Dutton, Gail (6 March 2019). "A Genetic Gold Rush Requires Biomolecular Tools". GEN - Genetic Engineering and Biotechnology News. Retrieved 11 February 2026.
  4. Feng, Venus; Lee, Yoojung (31 May 2018). "Road to China Drug Riches Runs Through the Bronx, New Jersey". Bloomberg. Retrieved 8 January 2026.
  5. Chen, I-Chun (9 November 2020). "Legend Biotech names Huang permanent CEO, Wang chairwoman". New York Business Journal. Retrieved 8 January 2026.
  6. "RESIGNATION OF ROTATING CHIEF EXECUTIVE OFFICER" (PDF). hkexnews.hk. GenScript. Retrieved 8 January 2026.
  7. "Meng Jiange "Robin" Bloomberg". Bloomberg. Bloomberg. Retrieved 9 April 2026.
  8. Dunleavy, Kevin (11 November 2024). "GenScript sets up operations and logistics center in Australia". Fierce Pharma. Retrieved 8 January 2026.
  9. "Advisory Board". www.genscript.com. GenScript. Retrieved 11 February 2026.
  10. "Annual Results Announcement For The Year Ended December 31, 2025" (PDF). hkexnews.hk. GenScript. Retrieved 9 April 2026.

Let me know if this is better Melis for GenScript (talk) 21:32, 30 June 2026 (UTC)Reply

I'll let others chime in, but this strikes me as a bit too WP:PROMO in tone. - Amigao (talk) 01:15, 8 July 2026 (UTC)Reply
Understood, more editor feedback is always helpful. User:Spencer Would you also have any interest in reviewing this smaller draft, since you updated the page earlier with the larger draft I presented? Feedback would be appreciated, thanks! Melis for GenScript (talk) 19:27, 23 July 2026 (UTC)Reply
Some thoughts: 1. The Lianhe Zaobao source is solid, but the link is now dead. You'll need to add an archived version to the citation. 2. Having reviewed their about pages and editorial policy, GEN appears to be a trade publication and not a reliable source. 3. I cannot find any editorial policy for Fierce Pharma, so I am also uncertain that it is a reliable source. 4. I don't see how the list of current leaders or advisory board members is due for inclusion; none of it is cited to independent, reliable sources. 5. I would condense the last paragraph down to "As of 2025, GenScript had a revenue of $959.5 million and over 6,165 employees." The other information does not seem relevant. Toadspike [Talk] 01:04, 19 September 2026 (UTC)Reply
@Melis for GenScript I have partially implemented this edit request, integrating the proposed text with the existing text as needed. The portions I did not include were mainly left out due to sourcing concerns. I will mark this edit request as resolved; you are welcome to propose including the information I left out in a new edit request with better sources. Toadspike [Talk] 01:15, 19 September 2026 (UTC)Reply

Update infobox

[edit]

Hello editors. While the post above is being considered, I would like to make a simple request to replace the infobox with the one below. The difference between the two are as follows:

  • Expands "industries" to be comprehensive
  • Adds founding location and number of years
  • Corrects the founder's names with sourcing
  • Clarifies CEO's position as "rotating"
  • Adds "Area served", "Services", "Revenue", "Number of employees" and "Subsidiaries"

As a note, I kept the website as the official URL template so it won't display properly here, but it is in use already on the page so it will work.

GenScript Biotech Corporation
TypePublic
SEHK: 1548
Industry
Founded2002; 24 years ago (2002) in New Jersey, United States
Founders
Headquarters
Area served
Worldwide
Key peopleSherry Shao, (rotating CEO)[4]
Services
Revenue$959.5 million[5] (2025)
Number of employees
6,165[5] (2025)
Subsidiaries
  • GenScript Life Science Group[6]
  • ProBio[7]
  • Bestzyme[8]

Please let me know if there are any questions!

References

  1. Feng, Venus; Lee, Yoojung (31 May 2018). "Road to China Drug Riches Runs Through the Bronx, New Jersey". Bloomberg. Retrieved 8 January 2026.
  2. Chen, I-Chun (9 November 2020). "Legend Biotech names Huang permanent CEO, Wang chairwoman". New York Business Journal. Retrieved 8 January 2026.
  3. "RESIGNATION OF ROTATING CHIEF EXECUTIVE OFFICER" (PDF). hkexnews.hk. Genscript. Retrieved 8 January 2026.
  4. Dunleavy, Kevin (11 November 2024). "GenScript sets up operations and logistics center in Australia". Fierce Pharma. Retrieved 8 January 2026.
  5. 1 2 "Annual Results Announcement For The Year Ended December 31, 2025" (PDF). GenScript. Retrieved 14 April 2026.
  6. Keenan, Joseph (2 November 2021). "GenScript embraces automation at its first cell, gene therapy manufacturing US site". Fierce Pharma. Retrieved 8 January 2026.
  7. Keenan, Joseph (26 June 2024). "Genscript's ProBio CDMO arm debuts new gene therapy production plant". Fierce Pharma. Retrieved 8 January 2026.
  8. "Annual Results Announcement For The Year Ended December 31, 2024" (PDF). hkexnews.hk. GenScript. Retrieved 8 January 2026.

Melis for GenScript (talk) 08:46, 15 August 2026 (UTC)Reply

Partly done: Replaced the infobox, but I removed the "Area served" parameter; it's not particularly encyclopedically important and ekes a little too close to promotional. Athanelar (talk) 17:11, 21 September 2026 (UTC)Reply
@Melis for GenScript I've also actually removed the 'services' section of the infobox too, since without any sources it mostly comes off as promotional. Please feel free to submit an edit request to re-add this services list, provided it can be sourced to an independent, reliable source. Athanelar (talk) 17:20, 21 September 2026 (UTC)Reply
[edit]

Hello editors. I uploaded the new logo for GenScript and would like to request that the infobox be updated to include it. See the link here: File:White BG GS Logo Primary RGB.svg.

Thank you! Melis for GenScript (talk) 19:30, 17 August 2026 (UTC)Reply

 Done Amigao (talk) 00:37, 18 August 2026 (UTC)Reply
Thank you Amigao! Did you happen to see the request right above this? It is also about the infobox. Cheers! Melis for GenScript (talk) 07:24, 20 August 2026 (UTC)Reply

History Section

[edit]

Hello editors, I would like to suggest updated content be added to this article in the "History" section. This includes the following:

  • Replace "In 2011, the company opened a subsidiary in Japan. In 2013, it established Bestzyme." with "In 2014, the unit Legend Biotech was founded.[1] "
  • this uses a better source and updates the text in alignment with that source
  • Replace, "In the same year, Genscript collaborated with Duke-NUS Medical School to develop and manufacture a serology test called cPass for the detection of COVID-19.[26] On November 6, the cPass test received emergency use authorization from the US FDA." with "After the COVID-19 pandemic began, GenScript collaborated with Duke-NUS Medical School to develop a way to test for antibodies in a person that could neutralize the coronavirus.[2] On November 6, the cPass test received emergency use authorization from the United States Food and Drug Administration.[3]"
  • this uses a better source and updates the text in alignment with that source
  • Add, "GenScript opened a 50,000-square-foot facility near its New Jersey headquarters in 2021 for developing new vaccines. Their cell and gene therapy manufacturing facility became the company's first automated plant in the country.[4] In 2022, it opened a protein and gene manufacturing facility in Singapore.[5]"

References

  1. Cite error: Unknown parameter "2018"" in <ref> tag; supported parameters are dir, follow, group, name (see the help page). Cite error: The named reference Preetika was invoked but never defined (see the help page).
  2. Timothy Goh (February 10, 2022). "GenScript's manufacturing facility boosts S'pore's role in fight against pandemic". The Straits Times.
  3. Liu, Angus (23 November 2020). "Genscript, Legend Biotech founder arrested in China for suspected smuggling". Fierce Pharma. Retrieved 8 January 2026.
  4. Keenan, Joseph (2 November 2021). "GenScript embraces automation at its first cell, gene therapy manufacturing US site". Fierce Pharma. Retrieved 8 January 2026.
  5. Timothy Goh (February 10, 2022). "GenScript's manufacturing facility boosts S'pore's role in fight against pandemic". The Straits Times.

Thanks, Melis for GenScript (talk) 20:59, 3 September 2026 (UTC)Reply

@Melis for GenScript The first footnote is empty, do you remember which source you wanted to cite for that? Toadspike [Talk] 12:42, 19 September 2026 (UTC)Reply
Not done: The first change suggested here has been made unnecessary by my other edits. The second suggested change is overly promotional in nature, replacing neutral language with language that inflates the beneficial impact of the company's actions. The third change is unnecessary routine trivia; we need to avoid corporate articles becoming coatracks of every trivial happening. Athanelar (talk) 17:46, 21 September 2026 (UTC)Reply